Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPortell Buj, Elena-
dc.contributor.authorBonet Rossinyol, Queralt-
dc.contributor.authorLópez Gavín, Alexandre-
dc.contributor.authorRoman, Angely-
dc.contributor.authorFernández Pittol, Mariana José-
dc.contributor.authorTudó i Vilanova, Griselda-
dc.contributor.authorGonzález Martín, Julián-
dc.description.abstractNontuberculous mycobacteria include 198 mycobacterial species. Among these, Mycobacteroides abscessus is a rapidly growing mycobacteria that causes lung and skin infections. M. abscessus lung infections are difficult to treat due to the high levels of resistance to several classes of antibiotics. The current treatment is based on combining at least two or three antibiotics. However, treatment outcomes remain very poor. The objective was to compare the in vitro activity of amikacin, tigecycline, imipenem, and clarithromycin, alone and in two different three-drug combinations (amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin) against seven M. abscessus subsp. abscessus clinical isolates using the time-kill assay. The two combinations showed greater activity than the antibiotics tested individually. Even though both combinations showed similar activity as well as no antagonistic activity, the combination including imipenem could not be an alternative treatment against M. abscessus subsp. abscessus lung infections caused by clarithromycin susceptible isolates. However, this combination could be considered against clarithromycin resistant isolates. Future studies are necessary to confirm this hypothesis.-
dc.format.extent6 p.-
dc.publisherSpringer Nature-
dc.relation.isformatofReproducció del document publicat a:
dc.relation.ispartofJournal of Antibiotics, 2021, vol. 74, p. 285-290-
dc.rightscc-by (c) Portell Buj, Elena et al., 2021-
dc.sourceArticles publicats en revistes (Fonaments Clínics)-
dc.subject.classificationMalalties del pulmó-
dc.subject.classificationFarmacologia respiratòria-
dc.subject.otherPulmonary diseases-
dc.subject.otherPulmonary pharmacology-
dc.titleComparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay-
Appears in Collections:Articles publicats en revistes (Fonaments Clínics)

Files in This Item:
File Description SizeFormat 
707171.pdf448.03 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons